N6-methyladenosine in 28S rRNA promotes oncogenic mRNA translation and tyrosine catabolism

Binbin Chen1, Li Li2, Ying Huang3

  • 1State Key Laboratory of Oncology in South China, Guangdong Provincial Clinical Research Center for Cancer, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China; Department of Clinical Nutrition, Sun Yat-sen University Cancer Center, Guangzhou 510060, P.R. China.

Cell Reports
|December 31, 2024
PubMed

Insights

ZCCHC4-mediated m6A modification on 28S rRNA drives cancer progression. Targeting the ZCCHC4-HPD axis offers a new strategy for treating intrahepatic cholangiocarcinoma (ICC).

Area of Science:

  • Molecular Biology
  • Oncology
  • Biochemistry

Background:

  • Aberrant N6-methyladenosine (m6A) mRNA modification is linked to cancer progression.
  • The role of m6A modification on ribosomal RNA (rRNA) in cancer remains largely unknown.

Purpose of the Study:

  • To investigate the function of ZCCHC4 and its m6A modification on 28S rRNA in cancer, particularly intrahepatic cholangiocarcinoma (ICC).
  • To elucidate the molecular mechanisms by which ZCCHC4 influences cancer progression and to identify potential therapeutic targets.

Main Methods:

  • Analysis of ZCCHC4 and m6A levels in various cancer types.
  • Functional studies using cell models and in vivo experiments to assess ZCCHC4's role in ICC progression.
  • Mechanistic investigations into ZCCHC4's interaction with the translation initiation complex and mRNA 3' UTR.

Main Results:

  • ZCCHC4 and its m6A modification on 28S rRNA are upregulated in cancers and associated with poor survival.
  • ZCCHC4 promotes ICC progression through its catalytic activity.
  • ZCCHC4 facilitates mRNA circularization and translation by interacting with eIF3G and mRNA 3' UTR.
  • HPD mediates ZCCHC4's effects on tyrosine catabolism and ICC progression.
  • Targeting HPD inhibits ICC progression in vivo.

Conclusions:

  • ZCCHC4-mediated m6A modification on 28S rRNA is a key driver of cancer progression.
  • The ZCCHC4-HPD axis represents a novel molecular mechanism regulating translation and tyrosine catabolism in ICC.
  • Targeting the ZCCHC4-HPD axis holds therapeutic potential for ICC treatment.

Related Concept Videos

Translation01:31

Translation

Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Proteins are...
14.5K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.4K
Nuclear Export of mRNA02:31

Nuclear Export of mRNA

Before mRNAs are exported to the cytoplasm, it is crucial to check each mRNA for structural and functional integrity. Eukaryotic cells use several different mechanisms, collectively known as mRNA surveillance, to look for irregularities in mRNAs. Irregular or aberrant mRNA are rapidly degraded by various enzymes. If a defective mRNA escapes the surveillance, it would be translated into a protein which would either be non-functional or not function properly. One of the primary irregularities in...
7.5K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.7K
The Nucleolus02:55

The Nucleolus

The nucleolus is the most prominent substructure of the nucleus. When it was first discovered, it was considered to be an isolated organelle that forms fibrils and granules. In 1931, the relationship between the nucleolus and chromosomes was first described by Heitz. He observed that the appearance and size of nucleolus varies depending on the stage of the cell cycle. He also noticed constricted regions on different chromosomes clustered together at definite cell cycle stages. These regions,...
8.7K
Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K